New review links Toxoplasma gondii to wider fertility risks: full analysis
A new review in Veterinary Sciences is reframing Toxoplasma gondii as more than a pregnancy-associated pathogen. Published April 30, 2026, “Toxoplasma gondii as a Direct Cause of Reproductive Dysfunction: Dual Threats to Male and Female Fertility” argues that the parasite may directly compromise reproductive function in both sexes, pulling together evidence on infertility, miscarriage, placental injury, endocrine effects, and sperm damage. (mdpi.com)
That’s a notable shift in emphasis. Toxoplasmosis has long been discussed mainly in the context of congenital infection, with CDC highlighting the highest risks for people who are newly infected during or just before pregnancy, as well as immunocompromised patients. But the new review contends that this framing may be too narrow, because reproductive harm may begin earlier, before conception or independent of fetal infection, through inflammatory and tissue-level effects in reproductive organs. (cdc.gov)
The broader context supports why the topic is getting renewed attention. CDC says toxoplasmosis is caused by a single-celled parasite that can persist long term in humans and other animals, and that infection can follow foodborne exposure, contaminated soil, or contact with cat feces. Cats play a key epidemiologic role as the definitive host, but veterinary guidance also stresses that direct transmission anxiety around household cats is often overstated. CAPC says most infected cats remain asymptomatic, cats with antibodies are unlikely to be shedding infectious oocysts, and fecal flotation is not recommended to determine an individual cat’s infection status. (cdc.gov)
The review’s fertility argument appears to rest on a mix of human, animal, and mechanistic literature. Supporting studies outside the review include a 2025 human-and-mouse study reporting that acute T. gondii infection adversely affected human spermatozoa and altered testicular and epididymal structures, with mitochondrial dysfunction flagged as one possible mechanism. A 2024 bovine study likewise found that T. gondii antigens compromised sperm quality and in vitro bull fertility measures. At the same time, a MotherToBaby evidence summary still says it is not known whether toxoplasmosis makes it harder to get pregnant in women, and notes that human studies on male fertility remain limited, which suggests the evidence base is evolving rather than settled. (pubmed.ncbi.nlm.nih.gov)
Direct outside expert reaction to this specific review was limited in publicly available sources, but recent literature is moving in the same direction. A 2026 review on toxoplasmosis in pregnancy underscores ongoing concern about maternal-fetal outcomes, while another recent overview describes clinical toxoplasmosis as a cross-disciplinary issue spanning obstetrics, transplantation, oncology, and other fields. Taken together, that suggests growing recognition that T. gondii has broader clinical implications than the classic congenital-infection narrative alone. That broader framing is an inference based on the direction of recent review literature. (pubmed.ncbi.nlm.nih.gov)
Why it matters: For veterinarians, especially those counseling breeding clients, shelters, feline practices, and pet parents who are pregnant or trying to conceive, the practical takeaway is nuance. This review does not mean cats should be stigmatized or relinquished. Instead, it strengthens the case for evidence-based prevention counseling: keep cats indoors when possible, avoid feeding raw meat, change litter boxes daily, use gloves for litter and gardening, and emphasize food safety because undercooked meat and contaminated produce are major exposure routes. That message aligns with CDC and CAPC guidance and supports a One Health role for veterinary teams in reducing unnecessary fear while sharpening prevention. (cdc.gov)
It may also matter for animal reproduction more directly. If future work confirms stronger links between T. gondii exposure and impaired fertility in males or females, reproductive management in breeding programs could eventually expand beyond abortion and congenital-disease concerns to include subfertility, semen quality, and early pregnancy loss. The current review helps put that possibility on the table, but it is still a review, not a new clinical trial or guideline update. (mdpi.com)
What to watch: Watch for follow-up studies that separate hypothesis from practice change, especially prospective human fertility data, breeding-animal studies, and any updates from public health or veterinary guideline groups on counseling, testing, or risk communication around toxoplasmosis and reproductive health. (pubmed.ncbi.nlm.nih.gov)